2-nitrophenyl-egta has been researched along with adenosine-3',5'-cyclic phosphorothioate in 1 studies
| Studies (2-nitrophenyl-egta) | Trials (2-nitrophenyl-egta) | Recent Studies (post-2010) (2-nitrophenyl-egta) | Studies (adenosine-3',5'-cyclic phosphorothioate) | Trials (adenosine-3',5'-cyclic phosphorothioate) | Recent Studies (post-2010) (adenosine-3',5'-cyclic phosphorothioate) |
|---|---|---|---|---|---|
| 57 | 0 | 8 | 507 | 0 | 47 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamiguchi, H; Ooashi, N | 1 |
1 other study(ies) available for 2-nitrophenyl-egta and adenosine-3',5'-cyclic phosphorothioate
| Article | Year |
|---|---|
The cell adhesion molecule L1 controls growth cone navigation via ankyrin(B)-dependent modulation of cyclic AMP.
Topics: Animals; Animals, Newborn; Ankyrins; Calcium; Calcium Signaling; Cells, Cultured; Cyclic AMP; Egtazic Acid; Ganglia, Spinal; Growth Cones; Mice; Mice, Knockout; Neural Cell Adhesion Molecule L1; Neurons; Protein Kinase Inhibitors; Thionucleotides | 2009 |